Gene · 4057
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T-cell Mediated Rejection Associated Microvascular Inflammation in the Allograft Kidney: RNAseq Analysis Using the Banff Human Organ Transplant Gene Panel. | Clin Transplant | 2024 | 39033507 | PubTator, text mining | PubMed |
| Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery. | Cardiovasc Diabetol | 2024 | 39014464 | PubTator, text mining | PubMed |
| [Bioinformatic analysis of immune-related transcription factors in diabetic kidney disease]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2024 | 38952087 | PubTator, text mining | PubMed |
| Acquired pellicle and biofilm engineering with CaneCPI-5: Insights from proteomic and microbiomics analysis. | Arch Oral Biol | 2024 | 38943859 | PubTator, text mining | PubMed |
| Identification of key genes as potential diagnostic biomarkers in sepsis by bioinformatics analysis. | PeerJ | 2024 | 38912048 | PubTator, text mining | PubMed |
| Genetic polymorphisms of inflammatory and bone metabolism related proteins in a population with dental implants of the Basque Country. A case-control study. | BMC Oral Health | 2024 | 38840172 | PubTator, text mining | PubMed |
| Investigation of lactotransferrin messenger RNA expression levels as an anti-type 2 asthma biomarker. | J Allergy Clin Immunol | 2024 | 38797239 | PubTator, text mining | PubMed |
| A Review for Uncovering the "Protein-Nanoparticle Alliance": Implications of the Protein Corona for Biomedical Applications. | Nanomaterials (Basel) | 2024 | 38786780 | PubTator, text mining | PubMed |
| A novel proteomic approach for the identification and relative quantification of disulfide-bridges in the human milk proteome. | J Proteomics | 2024 | 38723850 | PubTator, text mining | PubMed |
| A Review on cLF36, a Novel Recombinant Antimicrobial Peptide-Derived Camel Lactoferrin. | Probiotics Antimicrob Proteins | 2024 | 38722550 | PubTator, text mining | PubMed |
| Bioinformation Analysis of Differential Expression Proteins in Different Processes of COVID-19. | Viral Immunol | 2024 | 38717820 | PubTator, text mining | PubMed |
| Immune Characteristic Genes and Neutrophil Immune Transformation Studies in Severe COVID-19. | Microorganisms | 2024 | 38674681 | PubTator, text mining | PubMed |
| Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer. | Cancer Prev Res (Phila) | 2024 | 38669694 | PubTator, text mining | PubMed |
| Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/AKT/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38650146 | PubTator, text mining | PubMed |
| O-linked glycosylations in human milk casein and major whey proteins during lactation. | Int J Biol Macromol | 2024 | 38642686 | PubTator, text mining | PubMed |
| Assessment of the Conformation Stability and Glycosylation Heterogeneity of Lactoferrin by Native Mass Spectrometry. | J Agric Food Chem | 2024 | 38626386 | PubTator, text mining | PubMed |
| [Dynamic trajectory and cell communication of different cell clusters in malignant progression of glioblastoma]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2024 | 38595234 | PubTator, text mining | PubMed |
| Drug repositioning for immunotherapy in breast cancer using single-cell analysis. | NPJ Syst Biol Appl | 2024 | 38589404 | PubTator, text mining | PubMed |
| Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics. | Drug Resist Updat | 2024 | 38579635 | PubTator, text mining | PubMed |
| The correlation between human seminal plasma sialoproteins and ejaculate parameters. | Int J Biol Macromol | 2024 | 38574922 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4057/papers?page=9